Practice Change From Intermittent Medication Boluses to Bolusing From a Continuous Infusion in Pediatric Critical

Jessica L Hochstetler1, A Jill Thompson2, Natalie M Ball3

  • 1Department of Pharmacy, Texas Children's Hospital, Houston, TX.

Insights

Implementing a guideline to administer bolus medications from continuous infusions in Pediatric Intensive Care Units (PICUs) significantly reduced the time to start a bolus dose and improved nursing satisfaction. This change also optimized medication use without compromising patient safety.

Area of Science:

  • Pediatric critical care medicine
  • Quality improvement initiatives
  • Pharmacology and therapeutics

Background:

  • Continuous infusions are common for medications like dexmedetomidine, midazolam, fentanyl, morphine, vecuronium, or cisatracurium in Pediatric Intensive Care Units (PICUs).
  • Current practices for administering bolus doses may involve delays or inefficiencies.
  • Optimizing medication administration is crucial for patient safety and efficient care in PICUs.

Purpose of the Study:

  • To evaluate the impact of a new guideline for administering bolus medications from continuous infusions in PICUs.
  • To assess changes in nursing satisfaction, patient safety, central line entries, medication utilization, and cost following the guideline implementation.

Main Methods:

  • A pre- and post-implementation quality improvement study was conducted in a university-affiliated children's hospital.
  • The study included patients under 18 receiving specific continuous infusions in the PICU or pediatric cardiac ICU.
  • Key metrics included time to bolus administration, nursing satisfaction surveys, barcode scanning compliance, infusion pump overrides, central line entries, medication utilization patterns, and cost analysis.

Main Results:

  • The median time to begin a bolus dose decreased significantly by 169 seconds (p < 0.01).
  • Nursing satisfaction increased dramatically from 19.3% to 100%.
  • While barcode scanning compliance saw a slight decrease, infusion pump overrides remained within safe limits; central line entries were unaffected. Fentanyl boluses increased, but midazolam infusion dose and fentanyl infusion duration decreased, indicating optimized utilization. Annualized cost avoidance was $124,160.

Conclusions:

  • Implementing a guideline to administer bolus medications from continuous infusions in PICUs is effective in reducing administration time and enhancing nursing satisfaction.
  • This practice change optimizes medication utilization, including increased fentanyl boluses and decreased infusion durations for certain agents.
  • The study demonstrates that this quality improvement initiative can enhance efficiency and satisfaction without negatively impacting patient safety metrics.
Abstract

Related Concept Videos

Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
1.2K
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
759
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.0K
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection00:59

Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection

In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
429
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
363
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
267